Literature DB >> 7022716

The nature of the hepatitis B virus and its mode of replication.

C R Howard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7022716     DOI: 10.1007/bf01951490

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  86 in total

1.  Serological relationship of woodchuck hepatitis virus to human hepatitis B virus.

Authors:  B G Werner; J M Smolec; R Snyder; J Summers
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

2.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

3.  Differential distribution of Australia-antigen-associated particles in patients with liver diseases and normal carriers.

Authors:  J O Nielsen; M H Nielsen; P Elling
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

4.  Hepatitis B surface antigen production as a growth cycle-related terminal event in PLC/PRF/5 hepatoma cells.

Authors:  J A Copeland; J Skelly; G F Mann; C R Howard; A J Zuckerman
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

5.  The demonstration of subtype (D or Y)-specific determinants on the surface of the presumed hepatitis B virus.

Authors:  G Hess; J W Shih; P M Kaplan; J L Gerin
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

6.  HBsAg immune complexes in the course of infection with hepatitis B virus.

Authors:  K Madaliński; I Bragiel
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

7.  Analysis of hepatitis B surface antigen components solubilized with Triton X-100.

Authors:  J Skelly; C R Howard; A J Zuckerman
Journal:  J Gen Virol       Date:  1979-09       Impact factor: 3.891

8.  Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus.

Authors:  J L Gerin; E C Ford; R H Purcell
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

9.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

10.  Hepatitis B surface antigen produced by a human hepatoma cell line.

Authors:  G M MacNab; J J Alexander; G Lecatsas; E M Bey; J M Urbanowicz
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.